Eric T. Clambey, Ph.D.
Affiliations: | 2002 | Washington University, Saint Louis, St. Louis, MO |
Area:
Microbiology Biology, ImmunologyGoogle:
"Eric Clambey"Parents
Sign in to add mentor| Herbert W. Virgin, IV | grad student | 2002 | Washington University | |
| (Genetic analysis of gammaherpesvirus 68 latency and reactivation.) | ||||
Children
Sign in to add trainee| Abby K Kimball | research assistant | 2016-2019 | University of Colorado, Denver |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kleczko EK, Nguyen DT, Marsh KH, et al. (2023) Immune checkpoint activity regulates polycystic kidney disease progression. Jci Insight. 8 |
| Gray JI, Al-Khabouri S, Morton F, et al. (2020) Tolerance induction in memory CD4 T cells is partial and reversible. Immunology |
| Neuwelt AJ, Kimball AK, Johnson AM, et al. (2020) Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanisms. Journal For Immunotherapy of Cancer. 8 |
| Johnson AM, Bullock BL, Neuwelt AJ, et al. (2020) Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma. Journal of Immunology (Baltimore, Md. : 1950) |
| Johnson AM, Bulock BL, Neuwelt AJ, et al. (2020) Abstract A20: Cancer cell-intrinsic expression of MHCII regulates the immune microenvironment and response to immune therapy in lung adenocarcinoma Cancer Immunology Research. 8 |
| Tu MM, Lee FYF, Jones RT, et al. (2020) Abstract IA10: Developing rational combination therapy with checkpoint inhibitors Clinical Cancer Research. 26 |
| Oko LM, Kimball AK, Kaspar RE, et al. (2019) Multidimensional analysis of Gammaherpesvirus RNA expression reveals unexpected heterogeneity of gene expression. Plos Pathogens. 15: e1007849 |
| Bhatia S, Oweida A, Lennon S, et al. (2019) Inhibition of EphB4-ephrin-B2 signaling reprograms the tumor immune microenvironment in head and neck cancers. Cancer Research |
| Oweida AJ, Darragh L, Phan A, et al. (2019) The role of regulatory T cells in the response to radiation therapy in head and neck cancer. Journal of the National Cancer Institute |
| Tu MM, Lee FYF, Jones RT, et al. (2019) Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy. Science Advances. 5: eaav2437 |